Dr. Rehan Aziz, MD

Dr. Aziz practices at Hmhmg Specialty Care in Neptune, New Jersey.

Dr. Aziz's NPI, 1457391310, was assigned on June 8, 2006. Dr. Aziz graduated from Rutgers New Jersey Medical School in 2003. Dr. Aziz holds New Jersey license 25MA09827200.

Dr. Aziz's primary practice is Hmhmg Specialty Care, at 19 Davis Ave, Neptune, NJ 07753 in Monmouth County. The practice phone is (732) 807-0800.

Dr. Aziz's primary practice is Hmhmg Specialty Care in Neptune, New Jersey. Dr. Aziz is also affiliated with Jersey Shore University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Aziz to 1 more hospital, 5 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aziz practices, 7 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Aziz's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Aziz is board certified in geriatric psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Aziz's licenses on file in 2 states: New Jersey and Connecticut.

Dmand AI lists anxiety, depression, psychological distress, psychoses, schizophrenia and tobacco use among the conditions Dr. Aziz treats.

CMS data shows 289 Medicare services from Dr. Aziz across 9 procedure codes in 2024, for 142 Medicare patients. Medicare paid $25,733 for them.

CMS counts 142 Medicare patients who saw Dr. Aziz in 2024. The largest group is 75 to 84, with 59 patients. 75% of them have anxiety, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aziz's median patient age at 73, with 48% women.

In 2024, Dr. Aziz wrote 414 Medicare Part D claims for 101 patients. 97% of them were for generic drugs. CMS names the drug for 257 of them, across 10 drugs with 11 or more claims each, at $3,494 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Aziz for performance year 2024, reported as part of a group. Dr. Aziz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aziz as offering telehealth.

Dmand AI links 12 papers to Dr. Aziz, published from 2009 to 2020. 2018 was the busiest year, with 3. Dr. Aziz has published most often in Case Rep Psychiatry. Dr. Aziz's most frequent co-authors are Anthony M. Tobia, Rajesh Tampi, MD and Kenneth R. Kaufman, MD.

CMS Open Payments shows 13 general payments to Dr. Aziz from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $135.

Dr. Aziz graduated from Rutgers New Jersey Medical School in 2003.

Dr. Aziz is in network with 6 carriers, including Aetna, Excellus BlueCross BlueShield and Horizon Blue Cross Blue Shield of New Jersey. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.